China Healthwise Holdings (HKSE:00348) EBIT : HK$-123.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is China Healthwise Holdings EBIT?

China Healthwise Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was HK$-98.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-123.1 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. China Healthwise Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was -12.37%. China Healthwise Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -461.23%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. China Healthwise Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -127.90%.

China Healthwise Holdings EBIT Historical Data

The historical data trend for China Healthwise Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Healthwise Holdings EBIT Chart

China Healthwise Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-62.87

-54.08

-94.17

-49.10

-123.07

China Healthwise Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															-133.95	-12.10	-37.01	-24.77	-98.29

Competitive Comparison of China Healthwise Holdings's EBIT

For the Pharmaceutical Retailers subindustry, China Healthwise Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Healthwise Holdings's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Healthwise Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Healthwise Holdings's EV-to-EBIT falls into.

China Healthwise Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-123.1 Mil.

China Healthwise Holdings (HKSE:00348) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

China Healthwise Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-17.15 * ( 1 - 0.1% )	/	( (160.172	+	116.766)	/ 2 )
=	-17.13285	/	138.469
=	-12.37 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	233.941	-	14.98	-	( 58.789	-	max(0, 48.715	-	221.245	+	58.789	))
=	160.172

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	149.67	-	36.202	-	( 54.282	-	max(0, 142.953	-	139.655	+	54.282	))
=	116.766

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

China Healthwise Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-196.586	/	( ( (9.891 + max(38.702, 0))	+	(7.984 + max(28.668, 0)) )	/	2 )
=	-196.586	/	( ( 48.593	+	36.652 )	/	2 )
=	-196.586	/	42.6225
=	-461.23 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(4.707	+	42.777	+	6.198)	-	(14.98	+	0	+	0)
=	38.702

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(5.521	+	56.023	+	3.326)	-	(36.202	+	0	+	0)
=	28.668

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

China Healthwise Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-123.066	/	96.224
	=	-127.90 %

China Healthwise Holdings EBIT Related Terms

Thank you for viewing the detailed overview of China Healthwise Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

China Healthwise Holdings (HKSE:00348) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Healthwise Holdings Ltd (HKSE:00348) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

168-200 Connaught Road Central, Unit 1209, Shun Tak Centre, West Tower, Hong Kong, HKG

Website

http://www.healthwisehk.com/en

China Healthwise Holdings Ltd is an investment holding company. It operates in three segments: Chinese health products, Money lending business, and investment in financial instruments. The majority of its revenue comes from trading in Chinese health products, which include pharmaceutical products, ginseng, and dried seafood products. The company's geographical segments are Hong Kong and the PRC, of which key revenue is derived from Hong Kong.

Executives

Eternity Investment Limited	2201 Interest of corporation controlled by you
Heng Tai Consumables Group Limited	2201 Interest of corporation controlled by you
Heng Tai Finance Limited	2101 Beneficial owner
Lei Hong Wai	2101 Beneficial owner

China Healthwise Holdings (HKSE:00348) Headlines

No Headlines